
Altimmune, Inc. (NASDAQ:ALT) posted a loss for the second quarter on Tuesday.
The company posted a quarterly loss of 27 cents per share, versus market estimates of a loss of 32 cents per share. The company's quarterly sales came in at $5.000K.

Altimmune, Inc. (NASDAQ:ALT) posted a loss for the second quarter on Tuesday.
The company posted a quarterly loss of 27 cents per share, versus market estimates of a loss of 32 cents per share. The company's quarterly sales came in at $5.000K.